Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
22.90
+0.44 (1.96%)
At close: Jun 26, 2026, 4:00 PM EDT
22.70
-0.20 (-0.87%)
After-hours: Jun 26, 2026, 6:58 PM EDT
Nurix Therapeutics Employees
Nurix Therapeutics had 317 employees as of November 30, 2025. The number of employees increased by 31 or 10.84% compared to the previous year.
Employees
317
Change (1Y)
31
Growth (1Y)
10.84%
Revenue / Employee
$226,432
Profits / Employee
-$931,483
Market Cap
2.37B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Iovance Biotherapeutics | 975 |
| ADMA Biologics | 647 |
| Vericel | 398 |
| Harmony Biosciences Holdings | 293 |
| Kardigan | 241 |
| Stoke Therapeutics | 170 |
| Taysha Gene Therapies | 99 |
NRIX News
- 8 days ago - Nurix Therapeutics price target raised to $33 from $26 at Baird - TheFly
- 15 days ago - Nurix Therapeutics to Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy - GlobeNewsWire
- 17 days ago - Nurix Therapeutics price target raised to $32 from $30 at Truist - TheFly
- 17 days ago - Nurix Therapeutics price target raised to $32 from $30 at BTIG - TheFly
- 18 days ago - Nurix Therapeutics price target raised to $32 from $30 at Truist - TheFly
- 18 days ago - Nurix Therapeutics price target raised to $45 from $41 at Jefferies - TheFly
- 18 days ago - Nurix Therapeutics price target raised to $34 from $26 at Needham - TheFly
- 18 days ago - This Biotech Stock Is Up 11% on $2.3 Billion Roche Deal for Blood Cancer Drug - Barrons